We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
Turnover
16.67%
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+13.07%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$87.2M
AUM Growth
+$7.34M
(+9.2%)
Cap. Flow
+$584K
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
34.9%
Holding
132
New
15
Increased
19
Reduced
50
Closed
15
Avg Time Held
1.8
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$1.1M |
| 2 |
SNAK
Inventure Foods, Inc.
SNAK
|
+$947K |
| 3 |
VYNT
Vyant Bio, Inc. Common Stock
VYNT
|
+$929K |
| 4 |
H.B. Fuller
FUL
|
+$839K |
| 5 |
Cantaloupe
CTLP
|
+$779K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NSPH
NANOSPHERE INC. COM NEW
NSPH
|
+$1.56M |
| 2 |
STJ
St Jude Medical
STJ
|
+$1.37M |
| 3 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$1.25M |
| 4 |
Fastenal
FAST
|
+$1.22M |
| 5 |
Bank of America
BAC
|
+$675K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 60.45% |
| 2 | Technology | 13.15% |
| 3 | Industrials | 7.97% |
| 4 | Consumer Staples | 6.98% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$504B
| $1.08M | 1.24% |
17,475
-1,000
| -5% | -$60.9K |
2014 Q3
7 quarters
|
|
|
CAB
27
DELISTED
Cabela's Inc
CAB
| $1.08M | 1.23% |
21,500
+1,750
| +9% | +$87.1K |
2016 Q1
1 quarter
|
|
28
CVS Health
CVS
$118B
| $1.07M | 1.23% |
11,183
-1,000
| -8% | -$99.7K |
2013 Q2
12 quarters
|
|
29
Aflac
AFL
$60.1B
| $1.03M | 1.18% |
28,600
-1,500
| -5% | -$51.2K |
2015 Q2
4 quarters
|
|
30
Abbott
ABT
$181B
| $1.02M | 1.18% |
26,075
+1,900
| +8% | +$75.6K |
2014 Q1
9 quarters
|
|
|
31
DELISTED
Cantaloupe
CTLP
| $1.02M | 1.17% |
238,400
+181,750
| +321% | +$779K |
2014 Q1
9 quarters
|
|
32
SPS Commerce
SPSC
$3.07B
| $985K | 1.13% |
32,500
-1,500
| -4% | -$38.8K |
2015 Q2
4 quarters
|
|
33
DELISTED
Cogentix Medical, Inc.
CGNT
| $977K | 1.12% |
1,016,071
-25,190
| -2% | -$24.9K |
2015 Q2
4 quarters
|
|
34
Medtronic
MDT
$121B
| $959K | 1.1% |
11,050
-500
| -4% | -$40.4K |
2016 Q1
1 quarter
|
|
35
Microsoft
MSFT
$3.93T
| $959K | 1.1% |
18,735
| – | – |
2014 Q1
9 quarters
|
|
36
Johnson Controls International
JCI
$88.1B
| $873K | 1% |
18,837
+477
| +3% | +$21K |
2015 Q1
5 quarters
|
|
|
OUTR
37
DELISTED
OUTERWALL INC
OUTR
| $853K | 0.98% |
20,300
-650
| -3% | -$26.3K |
2013 Q4
10 quarters
|
|
|
38
H.B. Fuller
FUL
$2.76B
| $823K | 0.94% |
+18,700
| New | +$839K |
2016 Q2
0 quarters
|
|
39
CarParts.com
PRTS
$61M
| $820K | 0.94% |
20,760
-5,535
| -21% | -$192K |
2013 Q2
12 quarters
|
|
40
J.M. Smucker
SJM
$13.6B
| $815K | 0.93% |
5,350
-600
| -10% | -$79.8K |
2013 Q2
12 quarters
|
|
41
Cerenome
CNSY
$12.9M
| $811K | 0.93% |
2
+1
| +100% | +$597K |
2013 Q2
12 quarters
|
|
42
Xtant Medical Holdings
XTNT
$40.2M
| $790K | 0.91% |
34,482
-1,499
| -4% | -$38.6K |
2015 Q4
2 quarters
|
|
43
Stanley Black & Decker
SWK
$14B
| $779K | 0.89% |
7,000
-500
| -7% | -$55.6K |
2013 Q2
12 quarters
|
|
44
Expeditors International
EXPD
$25.5B
| $696K | 0.8% |
14,200
-2,000
| -12% | -$97.1K |
2015 Q2
4 quarters
|
|
45
Kimberly-Clark
KMB
$35.1B
| $687K | 0.79% |
5,000
-400
| -7% | -$52.3K |
2014 Q2
8 quarters
|
|
46
NCR Voyix
VYX
$1.05B
| $654K | 0.75% |
38,387
| – | – |
2015 Q2
4 quarters
|
|
47
DELISTED
Star Equity Holdings
STRR
| $646K | 0.74% |
2,510
-20
| -0.8% | -$5.29K |
2014 Q2
8 quarters
|
|
48
AngioDynamics
ANGO
$473M
| $644K | 0.74% |
+44,850
| New | +$560K |
2016 Q2
0 quarters
|
|
49
Verizon
VZ
$186B
| $605K | 0.69% |
10,830
+6,400
| +144% | +$332K |
2013 Q2
12 quarters
|
|
50
GSK
GSK
$99.2B
| $592K | 0.68% |
10,920
-840
| -7% | -$44.3K |
2013 Q2
12 quarters
|
|
Similar funds
AA
WA
AC
BCVI
HAP
RHIG
CWM
SI
Perkins Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Perkins Capital Management held 132 positions worth $87.2M, up 9.2% from $79.9M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Perkins Capital Management's Q2 2016 filing shows 15 new, 19 increased, 50 reduced and 15 closed positions. Its largest new stake was Boston Scientific: 50,650 shares worth $1.18M. The largest sale was NANOSPHERE INC. COM NEW, an estimated $1.56M.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 58% a quarter earlier, followed by Technology and Industrials.
- Perkins Capital Management's largest Q2 2016 buy was Boston Scientific: 50,650 shares worth $1.18M.
- Perkins Capital Management added most to Inventure Foods, Inc. in Q2 2016, an estimated $947K increase.
- Perkins Capital Management's biggest Q2 2016 reduction was NANOSPHERE INC. COM NEW, cutting an estimated $1.56M.
- Perkins Capital Management fully exited HD Supply Holdings, Inc. in Q2 2016, selling an estimated $1.25M.
- Perkins Capital Management's ten largest holdings make up 35% of its $87.2M portfolio in Q2 2016.
- Perkins Capital Management opened 15 new positions and closed 15 in Q2 2016.
- Perkins Capital Management's portfolio value rose 9.2% quarter-over-quarter to $87.2M.
Based on Perkins Capital Management's 13F filing for Q2 2016, filed 20 Jul 2016.